Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Sekitar 35% dari 901 orang dewasa yang menjalani pemeriksaan kesehatan secara rutin ditemukan mengalami NAFPD (nonalcoholic fatty pancreas disease). NAFPD berkaitan dengan manifestasi klinik (sindrom metabolik) MetS, adapun terapi yang diberikan sesuai dengan gejalanya seperti antihipertensi, statin, metformin dan faktor komorbid MetS, sehingga mungkin terjadi polifarmasi akibat multiterapi pengobatan. Dalam hal ini dibutuhkan obat tunggal yang dapat memperbaiki NAFPD pada tikus MetS salah satu kandidatnya yaitu 6-Gingerol. Tujuan dari penelitian ini untuk menganalisis efektifitas 6-Gingerol terhadap NAFPD akibat MetS melalui stress oksidatif pada organ pankreas tikus yang diinduksi HFD + Fruktosa 55% dan Streptozotocin 22mg/kg selama 8 minggu. Tikus yang mengalami sindrom metabolik diterapi dengan 6-Gingerol dosis 50,100 dan 200mg/kg selama 8 minggu. Setelah mencapai akhir terapi, serum dan jaringan pankreas di ambil dan di analisis kadar (tumor necrosis factor alpha) TNF-alpha, (interleukin-6) IL-6, (malondialdehyde) MDA, (glutathione peroxidase) GPx, amilase, akumulais lemak, ekspresi sel alfa dam beta pankreas sebagai parameter NAFPD. Hasil analisis menunjukan bahwa pemberian 6-Gingerol tidak dapat menurunkan aktivitas amilase serum, MDA, ekspresi mRNA IL-6, namun dapat meningkatkan aktivitas GPx, mengurangi akumulasi lemak, dan meningkatkan ekspresi insulin dan glukagon. Sehingga 6-Gingerol memiliki potensi sebagai agen terapeutik untuk memperbaiki NAFPD pada tikus MetS. ......About 35% of 901 adults who underwent routine health checks were found to have (nonalcoholic fatty pancreas disease) NAFPD. NAFPD is related to the clinical manifestations of (metabolic syndrome) MetS, while the therapy given is according to the symptoms. The therapies include: antihypertensives, statins, metformin, and MetS comorbid factors. Polypharmacy may occur as a result of multitherapy treatment. In this case, a single drug, namely 6-gingerol, is needed to improve NAFPD in the MetS rats. The aim of this study was to analyze the effectiveness of 6-Gingerol against MetS-induced NAFPD through oxidative stress in the pancreas of rats induced by HFD + Fructose 55% and Streptozotocin 22mg/kg for 8 weeks. Metabolic syndrome rats were treated with 6-gingerol doses of 50, 100, and 200 mg/kg for 8 weeks. After reaching the end of therapy, serum and pancreatic tissue were collected and analyzed for levels of (tumor necrosis factor alpha) TNF-α, (interleukin-6) IL-6, (malondialdehyde) MDA, (glutathione peroxidase) GPx, amylase, fat accumulation, cell expression pancreatic alpha and beta as parameters of NAFPD. The results of analysis showed that administering 6-gingerol did not significantly reduce serum amylase activity, MDA, the relative expression of IL-6, but it increased GPX activity, reduced fat accumulation, and increased insulin and glucagon expression in pancreatic tissue. Thus 6-Gingerol has the potential as a therapeutic agent to improve NAFPD in the MetS.

Abstrak :
Latar Belakang: Pemahaman tentang non-alcoholic fatty pancreas disease NAFPD dan makna klinisnya perlu terus ditingkatkan mengingat NAFPD diduga dapat berlanjut menjadi pankreatitis kronik dan memicu terjadinya kanker pankreas. NAFPD berhubungan erat dengan diabetes melitus tipe 2 DMT2 dan pasien diabetes berisiko 2x lipat untuk mengalami kanker pankreas. Proporsi dan faktor-faktor yang berhubungan dengan NAFPD pada populasi DMT2 belum pernah diteliti. Tujuan: Mengetahui proporsi dan faktor-faktor yang berhubungan dengan NAFPD pada populasi DM tipe 2. Metode: Pasien DMT2 dewasa yang berobat di poliklinik metabolik endokrin Rumah Sakit Cipto Mangunkusumo RSCM direkrut secara konsekutif pada studi potong lintang ini. Data usia, jenis kelamin, lama DM, komorbid, obat-obatan, lingkar pinggang, profil lipid dan HbA1C dikumpulkan. Ultrasonografi hepatobilier dilakukan pada setiap pasien untuk menentukan adanya NAFPD dan non-alcoholic fatty liver disease NAFLD . Hubungan NAFPD dengan parameter usia, jenis kelamin, lama DM, hipertensi, NAFLD, trigliserida dan HbA1C diuji kemaknaanya. Hasil Penelitian: Dari 171 pasien DMT2 yang direkrut dalam studi ini didapatkan proporsi NAFPD sebesar 48,5% (95%IK=41,2-55,9%). Analisis univariat menunjukkan perbedaan signifikan di antara kelompok NAFPD dan non-NAFPD dalam hal proporsi NAFLD (PR=1,96; 95%IK=1,41-2,74; p<0,001) dan hipertrigliseridemia (PR=1,38; 95%IK=1,02-1,86; p=0,042). Pada analisis multivariat usia lanjut (OR=2,15; 95%IK=1,10-4,23), NAFLD (OR=3,65; 95%IK=1,90-6,99) dan hipertrigliseridemia (OR=2,03; 95%IK=1,02-4,05) menunjukkan hubungan yang signifikan dengan kejadian NAFPD. Tidak ditemukan hubungan yang bermakna antara jenis kelamin, lama DM, hipertensi, serta kadar HbA1C dengan kejadian NAFPD. Kesimpulan: Proporsi NAFPD pada populasi DMT2 sebesar 48,5%. Usia lanjut, NAFLD dan hipertrigliseridemia merupakan faktor-faktor yang berhubungan dengan kejadian NAFPD pada pasien DMT2. ......Background: Understanding of non alcoholic fatty pancreas disease NAFPD and its clinical significance needs to be continuously improved as NAFPD might allegedly develop into chronic pancreatitis and further leads to pancreatic cancer. NAFPD is strongly associated with type 2 diabetes mellitus T2DM and long term T2DM is associated with a 1.5 to 2.0 fold increase in the risk of pancreatic cancer. The proportion of NAFPD and its associated factors in T2DM population has not been well investigated. Aim: To investigate the proportion of NAFPD and its associated factors in type 2 DM population. Methods: Adult T2DM patients who visited Diabetes Clinic, Cipto Mangunkusumo Hospital were consecutively recruited in this cross sectional study. Information about age, sex, duration of diabetes, komorbidities, medication, waist circumference, lipid profile and HbA1C were collected. Abdominal ultrasonography was performed on each subject to diagnose NAFPD and non alcoholic fatty liver disease NAFLD . Association of NAFPD with age, sex, duration of diabetes, hypertension, NAFLD, triglyceride and HbA1C were examined. Study Results: From total of 171 T2DM patients in this study, the proportion of NAFPD was 48.5% (95%CI= 41.2 to 55.9%). Univariate analysis showed significant differences between NAFPD and non-NAFPD group regarding proportion of NAFLD (PR=1.96; 95%CI=1.41-2.74; p<0.001) and hypertriglyceridemia (PR=1.38; 95%CI=1.02-1.86; p=0.042). On multivariate analysis older age (OR=2.15; 95%CI=1.10-4.23), NAFLD (OR=3.65; 95%CI=1.90-6.99), and hypertriglyceridemia (OR=2.03; 95%CI=1.02-4.05) showed significant association with NAFPD. There were no significant association found among sex, duration of diabetes, hypertension and high levels of HbA1C with NAFPD. Conclusion: The proportion of NAFPD in T2DM population is 48.5%. Older age, NAFLD and hypertriglyceridemia are associated factors of NAFPD in T2DM patient.